Metraipolis › archive › dc_eafaa47cb5b5

Combinatorial inhibition of IGF2BP3-regulated receptor tyrosine kinases offers a new therapeutic strategy for triple-negative breast cancer — Europe PMC PMID:41814321

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41814321
DOI
10.1186/s13046-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-04T13:26:33.436Z
SHA-256 of the archived text
c7909fc60e9e2b97b411072a0244a1d3d58fff1fdaf6718d2d26d807cbca2094
Stable URL of this page
https://metraipolis.com/documento/dc_eafaa47cb5b5

How to cite

Combinatorial inhibition of IGF2BP3-regulated receptor tyrosine kinases offers a new therapeutic strategy for triple-negative breast cancer — Europe PMC PMID:41814321 — Europe PMC (en), https://europepmc.org/article/MED/41814321 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eafaa47cb5b5 (Metraipolis archive dc_eafaa47cb5b5, sha256 c7909fc60e9e2b97b411072a0244a1d3d58fff1fdaf6718d2d26d807cbca2094)
BibTeX
@misc{dceafaa47cb5b5,
  title = {Combinatorial inhibition of IGF2BP3-regulated receptor tyrosine kinases offers a new therapeutic strategy for triple-negative breast cancer — Europe PMC PMID:41814321},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41814321},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eafaa47cb5b5; sha256 c7909fc60e9e2b97b411072a0244a1d3d58fff1fdaf6718d2d26d807cbca2094},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41814321. Agents can read the archived copy with the MCP tool read_document.